Hospital
Sacred Heart Health Services
Sacred Heart Health Services was paid $944K by Medicaid between Jan 2018 and Nov 2024, across 34 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 33% of everything it billed.
33Billing provider infoSACRED HEART HEALTH SERVICES
YANKTON, SD 57078
YANKTON, SD 57078
33aNPI1770693954assigned 08/30/2006
33bProvider typeRural Acute Care Hospital
28Total paid$944K
24GClaims40,717
24DCodes billed34
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,516 | $144K | |
| 2019 | 5,331 | $158K | |
| 2020 | 2,791 | $63K | |
| 2021 | 8,398 | $152K | |
| 2022 | 8,505 | $156K | |
| 2023 | 5,497 | $133K | |
| 2024incomplete | 4,679 | $137K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 33% | 9,867 | 5,451 | $310K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 2,731 | 2,308 | $242K |
| J3490 | Unclassified drugs | 13% | 7,834 | 2,721 | $125K |
| A9270 | Non-covered item or service | 6.7% | 8,174 | 1,127 | $64K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5.9% | 3,422 | 326 | $55K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.5% | 302 | 278 | $24K |
| 36415 | Collection of venous blood by venipuncture | 2.2% | 1,152 | 925 | $21K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.7% | 160 | 134 | $16K |
| 80053 | Comprehensive metabolic panel | 1.7% | 1,087 | 892 | $16K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 1.5% | 222 | 200 | $14K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.1% | 202 | 171 | $10K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 682 | 407 | $5K |
22 more codes
| J2704 | Injection, propofol, 10 mg | <1% | 340 | $5K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 318 | $5K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 410 | $4K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 229 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 141 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 88 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,915 | $3K |
| 11720 | <1% | 240 | $3K | |
| 11721 | <1% | 100 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 209 | $2K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 35 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 86 | $1K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 34 | $817.29 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 16 | $471.38 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 19 | $358.97 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 59 | $93.05 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 96 | $0.00 |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 136 | $0.00 |
| 99213 | Doctor's office visit, returning patient (routine) | 0% | 366 | $0.00 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 14 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 14 | $0.00 |
| 81001 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHWASINGER, TIM (DIRECTOR, PATIENT ACCOUNTS)
| Provider | Location | Paid |
|---|---|---|
| Sacred Heart Health Services | Yankton, SD | $769K |
| Sacred Heart Health Services | Yankton, SD | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.